National LTC Pharmacy Advocacy Group: Explosion of PBM DIR Fees Squeezes Elderly Patients and LTC Pharmacies Who Serve Them
FOR IMMEDIATE RELEASE
February 19, 2020
Washington, DC – The Senior Care Pharmacy Coalition (SCPC) today said a new analysis from XIL Consulting finding post-point-of-sale direct and indirect remuneration (DIR) transaction fees paid by pharmacies to pharmacy benefit managers (PBMs) and prescription drug plans (PDPs) rose by 1600% since 2013 helps renew attention on a previous CMS report finding DIR fees grew 45,000% from 2010-2017.
“This timely new report details yet another outlandish data point that should prompt renewed attention from lawmakers seeking to untangle the deceptive web of prescription drug pricing schemes employed by unaccountable middlemen,” stated Alan G. Rosenbloom, President and CEO of SCPC, the only Washington-based organization exclusively representing the interests of LTC pharmacies and the elderly patients they serve.
“It is our position that DIR fees are a windfall profit for PBMs and PDPs, and should be abolished – not reformed,” Rosenbloom continued. “The shocking continuation of astronomical DIR fee hikes throughout most of the past decade reiterates that elderly patients and the LTC pharmacies who serve them deserve systemic relief and reform.”
The SCPC President and CEO observed that DIR fees impact pharmacy markets differently, which drives different responses within the sector. “The unique nature of LTC pharmacies, the elderly patients they serve — and the fact they provide clinical and supportive services retail and other pharmacy groups do not — requires evaluating the regulatory landscape through a different, LTC pharmacy-specific prism,” he concluded.
####
The Senior Care Pharmacy Coalition (SCPC) is the only national organization exclusively representing the interests of LTC pharmacies. Its members operate in all 50 states and serve 850,000 patients daily in skilled nursing and assisted living facilities across the country. Visit seniorcarepharmacies.org to learn more.
Recent Posts
-
Experts fear damage to long-term care pharmacies as CMS touts newly negotiated drug prices
Even as the federal government on Thursday touted the billions of dollars in savings seniors can expect to see from newly negotiated, lower drug costs, pharmacies that supply long-term care facilities are warning of dire consequences.
-
Senior Care Pharmacy Coalition & “Save Senior Rx Care” Release Statement on Biden Administration’s Medicare Drug Pricing Announcement
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care pharmacy community, and the new Save Senior Rx Care campaign released a statement today in response to the new drug pricing announcement: “Today, the Biden Administration released the negotiated 2026 prices for the ten most expensive Medicare Part D drugs, as […]
-
LTC pharmacies demand ‘sustainable’ payment model ahead of 2026 drug-pricing changes
Many of the nation’s long-term care pharmacies are going to fall below “break-even” and may be forced out of business without additional support when drug-pricing policy changes kick in, sector advocates warned Wednesday.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.